Image Guided Radiation Therapy Market Scope
Image Guided Radiotherapy (IGRT) refers to any imaging during pre-treatment and treatment that prompts an activity that can improve or check radiotherapy precision. IGRT includes a wide range of techniques, from simple visual field arrangement checks to more complex volumetric imaging that allows direct visualization of the radiotherapy target volume. Image Guided Radiotherapy is the use of various scans and X-rays to treat a malignant growth. Image Guided Radiotherapy (IGRT) contours radiotherapy shafts around the malignant tissue. It employs X-rays and CT scans similar to those used prior to and during radiotherapy treatment. It increases the precision and accuracy of treatment delivery.
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Unit | Value (USD Million) |
Key Companies Profiled | GE Healthcare (United States), Moffitt Cancer Center (United States), ViewRay (United States), Hitachi, Ltd. (Japan), Siemens AG (Germany), Koninklijke Philips N.V. (Netherlands), Varian Medical Systems, Inc. (United States) and Vision RT Ltd. (United Kingdom) |
CAGR | % |
The market for Image Guided Radiation Therapy is highly competitive with several global as well as local players in the market. The global players are trying various strategies such as product innovation and using various marketing strategies to gain a higher market share. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Image Guided Radiation Therapy market throughout the predicted period.
GE Healthcare (United States), Moffitt Cancer Center (United States), ViewRay (United States), Hitachi, Ltd. (Japan), Siemens AG (Germany), Koninklijke Philips N.V. (Netherlands), Varian Medical Systems, Inc. (United States) and Vision RT Ltd. (United Kingdom) are some of the key players that are part of study coverage.
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
Segmentation Overview
The study have segmented the market of Global Image Guided Radiation Therapy market by Type , by Application (Hospitals, Ambulatory Surgical Centers, Clinics and Retail Pharmacies) and Region with country level break-up.
On the basis of geography, the market of Image Guided Radiation Therapy has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
region held largest market share in the year 2021.
On 25-Oct-2021, GE Healthcare showcase over 15 innovative multi-modality radiation therapy solutions, present medical practitioners imaging tools and support need to improve patient-centered care and advance the practice of precision medicine. GE Healthcare purposes to drive enhanced patient outcomes over cutting-edge multi-modality radiation therapy guidance solutions.
The FDA gave Accuray its 510(k) clearance for its Radixact treatment delivery platform designed for image-guided radiotherapy treatments for cancer patients. Additionally, the company said the regulatory agency gave its consent for Accuray’s Precision Treatment Planning System and iDMS Data Management System, components of the Radixact treatment platform.
Image Guided Radiation Therapy Market Dynamics:
Attributes | Details |
---|
Trends Influencing Market | - Prevalence of Various Cancer Surgeries
- Emergence of Advance and Effective Surgical Procedures
|
Key Restraints | - High Cost Associated with Image Guided Radiation Therapy
- Technological Complexity Associated with Image Guided Radiation Therapy Devices
|
Challenges | - Severe Adverse Effects Associated With the Therapy
- Difficulty in Diagnosis
|
Market Opportunities | - Emerging Demand from Developing Countries
- Increased Research and Development Investments
- Growth in the Healthcare Industry Worldwide
|
Key Target Audience
New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others